Nicotine pouches can be marketed as 'lower risk' than cigarettes. Is that dangerous?

The FDA's decision to allow Zyn nicotine pouches to be marketed as "lower risk" than cigarettes has sparked debate among public health experts. While they acknowledge that these pouches may assist current smokers in quitting traditional cigarettes, there's significant concern that they could lead to new addictions among young people. This move highlights the ongoing tension between encouraging harm reduction and protecting vulnerable populations from the dangers of nicotine addiction. The implications of this decision could shape public health policies and the future of nicotine regulation.